News | Thrombectomy Devices | June 11, 2015

Aspire Thrombectomy Device Effective in Removing Clot

Patient presented with cold leg

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

Clot in femoral artery caused by atrial fibrillation

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

First pass with aspirator

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

Final angio image showing clot removed

June 11, 2015 - C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove blood clots from a patient with a cold leg using the Aspire mechanical thrombectomy device.

The patient presented with a cold leg and in atrial fibrillation, and Smith performed an angiogram. The angiogram revealed a 30 mm occlusion in the common femoral artery. Patients with atrial fibrillation often produce a clot from the heart that then travels to other areas of the body. Smith made four passes with the Aspire mechanical thrombectomy device. The Aspire device removed the clot, which was evident on a completion angiogram.

"Patients presenting with a cold leg need treatment immediately," said Smith. "The Aspire device was simple to set up and effective in removing the clot. This is a valuable tool in our toolbox to treat cardiovascular disease."

The Aspire mechanical thrombectomy system allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during a procedure. Aspire mechanical aspirators also aspirate up to 280ml, almost 10 times more than basic syringe-based systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections to improve speed and performance.

The patented system is available by itself or in kits that include an over-the-wire or rapid exchange thrombectomy catheter. Aspire mechanical aspirators may also be connected to any thrombectomy catheter the clinician chooses.

For more information: www.controlmedtech.com

Related Content

Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Stroke History Higher in Asymptomatic Versus Symptomatic Atrial Fibrillation Patients
News | Stroke| June 28, 2017
Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with...
Sponsored Content | Videos | Venous Therapies| June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein th
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Overlay Init